1. Home
  2. EIG vs EVO Comparison

EIG vs EVO Comparison

Compare EIG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$42.35

Market Cap

980.0M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.06

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
EVO
Founded
2000
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.0M
934.1M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
EIG
EVO
Price
$42.35
$3.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
168.8K
95.4K
Earning Date
04-29-2026
04-08-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$858,700,000.00
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$1.26
$10.05
P/E Ratio
$80.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$2.31
52 Week High
$49.91
$4.80

Technical Indicators

Market Signals
Indicator
EIG
EVO
Relative Strength Index (RSI) 52.93 52.19
Support Level $41.08 $2.88
Resistance Level $43.19 $3.78
Average True Range (ATR) 1.10 0.12
MACD -0.08 -0.01
Stochastic Oscillator 69.23 33.33

Price Performance

Historical Comparison
EIG
EVO

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: